Dongfeng Pan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dongfeng Pan has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Yi Zhang
Department of Anesthesiology, University of Virginia, Charlottesville, Virginia 22908, USA
6 shared publications- Mahendra D. Chordia
Department of Chemistry, University of Virginia, Charlottesville, USA
5 shared publications Li Xiao
Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA 22908, USA
3 shared publicationsWei Yue
Department of Endocrinology and Metabolism, University of Virginia, Charlottesville, VA 22908, USA
2 shared publicationsXiuzhen Xie
Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA 22908, USA
2 shared publicationsBijoy Kundu
Department of Radiology, The University of Virginia, Charlottesville, Virginia
1 shared publication
Latest Publications
- Open Access
- 1 January 2022
- Published by Ivyspring International Publisher in Theranostics
- Vol. 12 (7) , 3024-3044
Critical role of FPR1 in splenocyte migration into brain to worsen inflammation and ischemic brain injury in mice
Background: Splenocyte contribution to ischemic brain injury has been suggested. It is not known whether this effect is due to systemic action or direct influence in ischemic brain tissues. It is also not known how splenocytes migrate into the brain and worsen neurological outcome after brain ischemia. We determined the role of formyl peptide receptor 1 (FPR1), a receptor expressed in monocytes, in the migration of splenocytes into ischemic brain tissues and the contribution of these splenocytes to ischemic brain injury.
- 1 January 2022
- Published by Ivyspring International Publisher in Theranostics
- Vol. 12 (7) , 3024-3044
Open AccessCritical role of FPR1 in splenocyte migration into brain to worsen inflammation and ischemic brain injury in mice
Background: Splenocyte contribution to ischemic brain injury has been suggested. It is not known whether this effect is due to systemic action or direct influence in ischemic brain tissues. It is also not known how splenocytes migrate into the brain and worsen neurological outcome after brain ischemia. We determined the role of formyl peptide receptor 1 (FPR1), a receptor expressed in monocytes, in the migration of splenocytes into ischemic brain tissues and the contribution of these splenocytes to ischemic brain injury.
- 1 February 2016
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (3) , 1052-1055
Multimodal formyl peptide receptor 1 targeted inflammation imaging probe: cFLFLF-MHI-DOTA
- 1 February 2016
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (3) , 1052-1055
Multimodal formyl peptide receptor 1 targeted inflammation imaging probe: cFLFLF-MHI-DOTA
- 1 December 2013
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 23 (23) , 6350-6354
Novel cancer-targeting SPECT/NIRF dual-modality imaging probe 99mTc-PC-1007: Synthesis and biological evaluation
- 1 December 2013
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 23 (23) , 6350-6354
Novel cancer-targeting SPECT/NIRF dual-modality imaging probe 99mTc-PC-1007: Synthesis and biological evaluation
- 1 April 2013
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 40 (3) , 351-360
Heptamethine cyanine based 64Cu-PET probe PC-1001 for cancer imaging: Synthesis and in vivo evaluation
- 1 April 2013
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 40 (3) , 351-360
Heptamethine cyanine based 64Cu-PET probe PC-1001 for cancer imaging: Synthesis and in vivo evaluation
- Open Access
- 16 April 2009
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 50 (5) , 790-797
A Novel Neutrophil-Specific PET Imaging Agent: cFLFLFK-PEG-64Cu
The synthesis and validation of a new, highly potent 64Cu-labeled peptide, cFLFLFK-PEG-64Cu, that targets the formyl peptide receptor (FPR) on leukocytes is described. The peptide ligand is an antagonist of the FPR, designed not to elicit a chemotactic response resulting in neutropenia. Evidence for the selective binding of this synthesized ligand to neutrophils is provided. PET properties of the compound were evaluated in a mouse model of lung inflammation. Methods: The FPR-specific peptide, cinnamoyl-F-(D)L-F-(D)L-FK (cFLFLF), was sequentially conjugated with a bifunctional polyethylene glycol moiety (PEG, 3.4 kD) and a 2,2′,2″,2″′-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid (DOTA) through a lysine (K) spacer and finally labeled with 64Cu-CuCl2 to form cFLFLFK-PEG-64Cu. The binding affinity and stimulation potency of the ligand toward human neutrophils were assessed in vitro. Blood kinetic and organ biodistribution properties of the peptide were studied in the mouse. Ten male C57BL/6 mice were used in this study; 4 control mice and 6 administered Klebsiella pneumonia. PET/CT scans were performed to assess the localization properties of the labeled peptide in lungs 18 h after tracer administration. Lung standardized uptake values (SUVs) were correlated with lung neutrophil activity as measured by myeloperoxidase assays. Immunohistochemistry was performed to confirm that neutrophils constitute the majority of infiltrating leukocytes in lung tissue 24 h after Klebsiella exposure. Results: In vitro binding assays of the compound cFLFLFK-PEG-64Cu to the neutrophil FPR yielded a dissociation constant of 17.7 nM. The functional superoxide stimulation assay exhibited negligible agonist activity of the ligand with respect to neutrophil superoxide production. The pegylated peptide ligand exhibited a blood clearance half-life of 55 ± 8 min. PET 18 h after tracer administration revealed mean lung SUVs and lung myeloperoxidase activities for Klebsiella-infected mice that were 5- and 6-fold higher, respectively, than those for control mice. Immunohistochemistry staining confirmed that the cellular infiltrate in lungs of Klebsiella-infected mice was almost exclusively neutrophils at the time of imaging. Conclusion: This new radiolabeled peptide targeting the FPR binds to neutrophils in vitro and accumulates at sites of inflammation in vivo. This modified peptide may prove to be a useful tool to probe inflammation or injury.
- 16 April 2009
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 50 (5) , 790-797
Open AccessA Novel Neutrophil-Specific PET Imaging Agent: cFLFLFK-PEG-64Cu
The synthesis and validation of a new, highly potent 64Cu-labeled peptide, cFLFLFK-PEG-64Cu, that targets the formyl peptide receptor (FPR) on leukocytes is described. The peptide ligand is an antagonist of the FPR, designed not to elicit a chemotactic response resulting in neutropenia. Evidence for the selective binding of this synthesized ligand to neutrophils is provided. PET properties of the compound were evaluated in a mouse model of lung inflammation. Methods: The FPR-specific peptide, cinnamoyl-F-(D)L-F-(D)L-FK (cFLFLF), was sequentially conjugated with a bifunctional polyethylene glycol moiety (PEG, 3.4 kD) and a 2,2′,2″,2″′-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid (DOTA) through a lysine (K) spacer and finally labeled with 64Cu-CuCl2 to form cFLFLFK-PEG-64Cu. The binding affinity and stimulation potency of the ligand toward human neutrophils were assessed in vitro. Blood kinetic and organ biodistribution properties of the peptide were studied in the mouse. Ten male C57BL/6 mice were used in this study; 4 control mice and 6 administered Klebsiella pneumonia. PET/CT scans were performed to assess the localization properties of the labeled peptide in lungs 18 h after tracer administration. Lung standardized uptake values (SUVs) were correlated with lung neutrophil activity as measured by myeloperoxidase assays. Immunohistochemistry was performed to confirm that neutrophils constitute the majority of infiltrating leukocytes in lung tissue 24 h after Klebsiella exposure. Results: In vitro binding assays of the compound cFLFLFK-PEG-64Cu to the neutrophil FPR yielded a dissociation constant of 17.7 nM. The functional superoxide stimulation assay exhibited negligible agonist activity of the ligand with respect to neutrophil superoxide production. The pegylated peptide ligand exhibited a blood clearance half-life of 55 ± 8 min. PET 18 h after tracer administration revealed mean lung SUVs and lung myeloperoxidase activities for Klebsiella-infected mice that were 5- and 6-fold higher, respectively, than those for control mice. Immunohistochemistry staining confirmed that the cellular infiltrate in lungs of Klebsiella-infected mice was almost exclusively neutrophils at the time of imaging. Conclusion: This new radiolabeled peptide targeting the FPR binds to neutrophils in vitro and accumulates at sites of inflammation in vivo. This modified peptide may prove to be a useful tool to probe inflammation or injury.
- 1 February 2007
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (3) , 741-744
Synthesis of a technetium-99m labeled tricyclic ganciclovir analog for non-invasive reporter gene expression imaging
- 1 February 2007
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (3) , 741-744
Synthesis of a technetium-99m labeled tricyclic ganciclovir analog for non-invasive reporter gene expression imaging